{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:40:13Z","timestamp":1787636413752,"version":"build-2736575974"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Foundation for Science and Technology, I.P.","award":["SFRH\/BD\/123483\/2016"],"award-info":[{"award-number":["SFRH\/BD\/123483\/2016"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejpb.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T02:38:53Z","timestamp":1524623933000},"page":"131-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Challenges in the local delivery of peptides and proteins for oral mucositis management"],"prefix":"10.1016","volume":"128","author":[{"given":"Jo\u00e3o C.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o D.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.04.025_b0005","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.oooo.2012.02.016","article-title":"Oral local drug delivery and new perspectives in oral drug formulation","volume":"114","author":"Paderni","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2018.04.025_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1601-0825.2011.01793.x","article-title":"Local drug delivery for oral mucosal diseases: challenges and opportunities","volume":"17","author":"Sankar","year":"2011","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejpb.2018.04.025_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2005.03.022","article-title":"Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide","volume":"105","author":"Nicolazzo","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1208\/s12249-016-0533-z","article-title":"Treatment of radiation-induced oral mucositis using a novel accepted taste of prolonged release mucoadhesive bi-medicated double-layer buccal films","volume":"18","author":"Abo Enin","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.04.025_b0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.drudis.2007.10.018","article-title":"Drug delivery from the oral cavity: focus on a novel mechatronic delivery device","volume":"13","author":"Scholz","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2018.04.025_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2011.02.008","article-title":"New developments and opportunities in oral mucosal drug delivery for local and systemic disease","volume":"64","author":"Hearnden","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.addr.2003.10.016","article-title":"Lectin-mediated drug delivery in the oral cavity","volume":"56","author":"Smart","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b0040","first-page":"e15","article-title":"Protocols for management of oral complications of chemotherapy and\/or radiotherapy for oral cancer: Systematic review and meta-analysis current","volume":"22","author":"Carneiro-Neto","year":"2017","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.ejpb.2018.04.025_b0045","first-page":"e201","article-title":"Treatment of oral mucositis due to chemotherapy","volume":"8","author":"Chaveli-Lopez","year":"2016","journal-title":"J. Clin. Exp. Dent."},{"key":"10.1016\/j.ejpb.2018.04.025_b0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1191\/1078155205jp166oa","article-title":"Survey of topical oral solutions for the treatment of chemo-induced oral mucositis","volume":"11","author":"Chan","year":"2005","journal-title":"J. Oncol. Pharm. Pract.: Off. Publ. Int. Soc. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ejpb.2018.04.025_b0055","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/cncr.28553","article-title":"Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck","volume":"120","author":"Allison","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0060","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1080\/14656566.2016.1217993","article-title":"Pharmacotherapy for the management of cancer regimen-related oral mucositis","volume":"17","author":"Villa","year":"2016","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/14728214.2014.946403","article-title":"Emerging therapies for the prevention and treatment of oral mucositis","volume":"19","author":"Yuan","year":"2014","journal-title":"Expert Opin. Emerging Drugs"},{"key":"10.1016\/j.ejpb.2018.04.025_b0070","first-page":"389","article-title":"Evaluation of efficacy of Caphosol in prevention and alleviation of acute side effects in patients treated with radiotherapy for head and neck cancers","volume":"20","author":"Kiprian","year":"2016","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.2016.380","article-title":"Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation","volume":"116","author":"Treister","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1017\/S1460396912000581","article-title":"The use of MuGard\u2122, Caphosol\u00ae and Episil\u00ae in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck","volume":"13","author":"Pettit","year":"2014","journal-title":"J. Radiother. Pract."},{"key":"10.1016\/j.ejpb.2018.04.025_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00520-013-2015-0","article-title":"Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children?: results from a prospective multicenter double blind randomized controlled trial","volume":"22","author":"Raphael","year":"2014","journal-title":"Supportive Care Cancer: Off. J. Multinational Assoc. Support. Care Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/17425255.4.11.1449","article-title":"Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions","volume":"4","author":"Buchsel","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00520-006-0171-1","article-title":"Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis","volume":"15","author":"Barber","year":"2007","journal-title":"Supportive Care Cancer: Off. J. Multinational Assoc. f Supportive Care Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s40496-015-0069-4","article-title":"Oral mucositis induced by anticancer therapies","volume":"2","author":"Al-Ansari","year":"2015","journal-title":"Curr. Oral Health Rep."},{"key":"10.1016\/j.ejpb.2018.04.025_b0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ar700108g","article-title":"Targeted cancer therapy: conferring specificity to cytotoxic drugs","volume":"41","author":"Chari","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","article-title":"Targeted cancer therapy: the next generation of cancer treatment","volume":"12","author":"Baudino","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0115","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/OTT.S96899","article-title":"Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy","volume":"9","author":"Kwon","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.ejpb.2018.04.025_b0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00520-012-1594-5","article-title":"Study group of the multinational association of supportive care in cancer\/international society of oral systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients","volume":"21","author":"Raber-Durlacher","year":"2013","journal-title":"Supportive Care Cancer: Off. J. Multinational Assoc. Supportive Care Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389201013378734","article-title":"Delivery of bioactive peptides and proteins across oral (buccal) mucosa","volume":"2","author":"Senel","year":"2001","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5731\/pdajpst.2012.00877","article-title":"Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems","volume":"66","author":"Shinkar","year":"2012","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1368-8375(97)00065-1","article-title":"Scoring oral mucositis","volume":"34","author":"Parulekar","year":"1998","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpainsymman.2005.12.020","article-title":"Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors","volume":"32","author":"Wong","year":"2006","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.ejpb.2018.04.025_b0145","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother. Oncol.: J. Eur. Soc. Therapeutic Radiol. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0022034516641890","article-title":"Host-microbiome cross-talk in oral mucositis","volume":"95","author":"Vasconcelos","year":"2016","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"Guidelines leadership group of the multinational association of supportive care in, O. International Society of Oral, MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0170","first-page":"2285","article-title":"Radiation induced oral mucositis: a review of current literature on prevention and management","volume":"273","author":"Mallick","year":"2016","journal-title":"Eur. Arch. Oto-rhino-Laryngol.: Off. J. Eur. Federation Oto-Rhino-Laryngol. Soc. (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery"},{"key":"10.1016\/j.ejpb.2018.04.025_b0175","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.oooo.2016.07.021","article-title":"Effect of G-CSF on oral mucositis and traumatic ulcers produced in the tongue of rats undergoing radiotherapy: clinical and histologic evaluation","volume":"122","author":"Jasper","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0964-1955(96)00043-7","article-title":"Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis","volume":"33","author":"Sonis","year":"1997","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0185","first-page":"1135","article-title":"Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3","volume":"54","author":"Sonis","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1368-8375(01)00107-5","article-title":"Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster","volume":"38","author":"Clarke","year":"2002","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0030-4220(92)90402-C","article-title":"Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy","volume":"74","author":"Sonis","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1269\/jrr.10069","article-title":"Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis","volume":"51","author":"Ryu","year":"2010","journal-title":"J. Radiation Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0205","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2006.10.038","article-title":"Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats","volume":"67","author":"Lee","year":"2007","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2018.04.025_b0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2184.35.s1.8.x","article-title":"The effects of keratinocyte growth factor in preclinical models of mucositis","volume":"35","author":"Farrell","year":"2002","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.ejpb.2018.04.025_b0215","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.oraloncology.2010.04.008","article-title":"AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis","volume":"46","author":"Caluwaerts","year":"2010","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1368-8375(00)00012-9","article-title":"Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters","volume":"36","author":"Sonis","year":"2000","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/09553000802007601","article-title":"Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation","volume":"84","author":"Ara","year":"2008","journal-title":"Int. J. Radiation Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3816\/SCT.2005.n.006","article-title":"Single-dose prevention or short-term treatment with fibroblast growth factor-20 (CG53135-05) reduces the severity and duration of oral mucositis","volume":"2","author":"Alvarez","year":"2005","journal-title":"Supportive Cancer Therapy"},{"key":"10.1016\/j.ejpb.2018.04.025_b0235","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2354.2008.00971.x","article-title":"Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies","volume":"18","author":"Hong","year":"2009","journal-title":"Eur. J. Cancer Care (Engl)"},{"key":"10.1016\/j.ejpb.2018.04.025_b0240","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1002\/cncr.24414","volume":"115","author":"Wu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1079-2104(99)70034-X","article-title":"GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study","volume":"88","author":"Bez","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontics"},{"key":"10.1016\/j.ejpb.2018.04.025_b0250","first-page":"197","article-title":"Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs","volume":"10","author":"Mantovani","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejpb.2018.04.025_b0255","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bmt.1701434","article-title":"Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial","volume":"22","author":"Karthaus","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0260","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1200\/jco.2004.22.14_suppl.5587","article-title":"Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): impact on mucositis","volume":"22","author":"Su","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0265","first-page":"1363","article-title":"Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis","volume":"5","author":"Wymenga","year":"1999","journal-title":"Clin. Cancer Research: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0270","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2008.21.2381","article-title":"Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy","volume":"27","author":"Peterson","year":"2009","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0275","first-page":"Cd011990","article-title":"Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors","volume":"11","author":"Riley","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b0280","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1158\/1078-0432.CCR-04-1118","article-title":"Phase I\/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation","volume":"10","author":"Freytes","year":"2004","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0285","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/bmt.2011.261","article-title":"Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Jagasia","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0290","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-153-6-201009210-00003","article-title":"Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial","volume":"153","author":"Vadhan-Raj","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0295","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0300","first-page":"477","article-title":"Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience","volume":"12","author":"Rzepecki","year":"2007","journal-title":"J. B.U.ON.: Off J. Balkan Union Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0305","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bmt.1705846","article-title":"The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant","volume":"40","author":"Nasilowska-Adamska","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0310","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood.V110.11.615.615","article-title":"A randomized placebo controlled Phase II trial of prevention of severe oral mucositis using single dose velafermin in patients receiving myeloablative therapy and autologous hematopoietic stem cell transplant (AHSCT)","volume":"110","author":"Schuster","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2018.04.025_b0315","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1200\/jco.2006.24.18_suppl.6537","article-title":"Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single dose velafermin (CG53135\u201305) for the prevention of oral mucositis","volume":"24","author":"Schuster","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0320","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2016.02.016","article-title":"Pharmacokinetics, and efficacy of palifermin in children and adolescents with acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium trial","volume":"22","author":"Morris","year":"2016","journal-title":"Biol. Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0325","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2005.04.1152","article-title":"Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy","volume":"24","author":"Rosen","year":"2006","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0330","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","article-title":"Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study","volume":"29","author":"Le","year":"2011","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0335","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95\u201301 Study","volume":"23","author":"Fournel","year":"2005","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/JTO.0b013e31822f6526","article-title":"Randomized Phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer","volume":"7","author":"Schuette","year":"2012","journal-title":"J. Thoracic Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0345","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0350","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/jcmm.12169","article-title":"Clinical applications of palifermin: amelioration of oral mucositis and other potential indications","volume":"17","author":"Vadhan-Raj","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0355","doi-asserted-by":"crossref","unstructured":"O. Milne, B. Cutts, C. McLean, D. Gin, Palifermin-induced acral erythrodysaesthesia variant in the treatment of acute myeloid leukaemia, 2011.","DOI":"10.1111\/j.1440-0960.2010.00682.x"},{"key":"10.1016\/j.ejpb.2018.04.025_b0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2017.12.011","article-title":"Role of drugs in the prevention and amelioration of radiation induced toxic effects","volume":"819","author":"Patyar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-014-1485-1","article-title":"Enhancing the buccal mucosal delivery of peptide and protein therapeutics","volume":"32","author":"Caon","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(01)00269-3","article-title":"Drug permeation enhancement via buccal route: possibilities and limitations","volume":"72","author":"Senel","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b0375","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/03639045.2014.892960","article-title":"Novel strategies for the buccal delivery of macromolecules","volume":"40","author":"Morales","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0380","unstructured":"J.T.L. Smith, Anti-il-6 antibodies for the treatment of oral mucositis, Google Patents, 2012."},{"key":"10.1016\/j.ejpb.2018.04.025_b0385","unstructured":"B.S. Fox, Methods of treating mucositis using anti-TNF antibodies, Google Patents, 2013."},{"key":"10.1016\/j.ejpb.2018.04.025_b0390","doi-asserted-by":"crossref","first-page":"E702","DOI":"10.1073\/pnas.1322691111","article-title":"Critical role for IL-1\u03b2 in DNA damage-induced mucositis","volume":"111","author":"Kanarek","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0395","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2009.06.006","article-title":"Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies","volume":"92","author":"Haagen","year":"2009","journal-title":"Radiother. Oncol.: J. Eur. Soc. Therapeutic Radiol. Oncol."},{"issue":"2010","key":"10.1016\/j.ejpb.2018.04.025_b0400","first-page":"123","article-title":"TNF and oral mucositis: response to effect of selective inhibitors of inflammation on oral mucositis: preclinical studies. Radiother Oncol 2009; 92:472-6","volume":"94","author":"Fox","year":"2009","journal-title":"Radiother. Oncol.: J. Eur. Soc. Therapeutic Radiol. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0405","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphar.2017.00354","article-title":"New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury","volume":"8","author":"Cinausero","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0410","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tranon.2017.05.001","article-title":"Chemotherapy induces oral mucositis in mice without additional noxious stimuli","volume":"10","author":"Bertolini","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0415","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00066-017-1119-8","article-title":"Early inflammatory changes in radiation-induced oral mucositis","volume":"193","author":"Gruber","year":"2017","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0420","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijrobp.2016.08.047","article-title":"Salivary cytokine levels and oral mucositis in head and neck cancer patients treated with chemotherapy and radiation therapy","volume":"96","author":"Bossi","year":"2016","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"issue":"Suppl.","key":"10.1016\/j.ejpb.2018.04.025_b0425","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.clinthera.2007.12.004","article-title":"Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation","volume":"29","author":"Fall-Dickson","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejpb.2018.04.025_b0430","unstructured":"Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects."},{"key":"10.1016\/j.ejpb.2018.04.025_b0435","unstructured":"S.B.I. Research, Topical Anti-TNF Antibody for Oral Mucositis, 2009."},{"key":"10.1016\/j.ejpb.2018.04.025_b0440","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.3118","article-title":"Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis","volume":"19","author":"Han","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0445","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s13238-014-0130-4","article-title":"The role of Smad7 in oral mucositis","volume":"6","author":"Bian","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejpb.2018.04.025_b0450","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/cbir.1995.1086","article-title":"P. van Bergen en Henegouwen, the epidermal growth factor","volume":"19","author":"Boonstra","year":"1995","journal-title":"Cell Biol. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2018.04.025_b0455","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00004836-199800001-00004","article-title":"The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways","volume":"27","author":"Tarnawski","year":"1998","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0460","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1479-666X(08)80114-X","article-title":"Epidermal growth factor therapy and wound healing\u2013past, present and future perspectives","volume":"6","author":"Hardwicke","year":"2008","journal-title":"Surgeon: J. Royal Colleges Surgeons Edinburgh Ireland"},{"key":"10.1016\/j.ejpb.2018.04.025_b0465","doi-asserted-by":"crossref","unstructured":"Enhancement of epidermal regeneration by biosynthetic epidermal growth factor, J. Experimental Med. 163 (1986) 1319\u20131324.","DOI":"10.1084\/jem.163.5.1319"},{"key":"10.1016\/j.ejpb.2018.04.025_b0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198907133210203","article-title":"Enhancement of wound healing by topical treatment with epidermal growth factor","volume":"321","author":"Brown","year":"1989","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0475","first-page":"E620","article-title":"Effect of salivary epidermal growth factor on wound healing of tongue in mice","volume":"260","author":"Noguchi","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0480","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-481X.2009.00622.x","article-title":"Epidermal growth factor in clinical practice \u2013 a review of its biological actions, clinical indications and safety implications","volume":"6","author":"Berlanga-Acosta","year":"2009","journal-title":"Int. Wound J."},{"key":"10.1016\/j.ejpb.2018.04.025_b0485","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1067\/moe.2000.106343","article-title":"Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck","volume":"89","author":"Dumbrigue","year":"2000","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.ejpb.2018.04.025_b0490","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z","article-title":"The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy","volume":"89","author":"Epstein","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0495","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1368-8375(97)00009-2","article-title":"Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer","volume":"33","author":"Epstein","year":"1997","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0500","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.23359","article-title":"Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation","volume":"88","author":"Kim","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0505","doi-asserted-by":"crossref","first-page":"e0168854","DOI":"10.1371\/journal.pone.0168854","article-title":"Topical recombinant human epidermal growth factor for oral mucositis induced by intensive chemotherapy with hematopoietic stem cell transplantation: final analysis of a randomized, double-blind, placebo-controlled, Phase 2 Trial","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.04.025_b0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cyto.2014.08.003","article-title":"Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review","volume":"71","author":"Singh","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2018.04.025_b0515","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V67.2.257.257","article-title":"The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors","volume":"67","author":"Metcalf","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2018.04.025_b0520","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2302\/kjm.46.184","article-title":"Keratinocyte growth stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF)","volume":"46","author":"Tanaka","year":"1997","journal-title":"Keio J. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0525","first-page":"943","article-title":"In vitro effects of GM-CSF on mature peripheral blood neutrophils","volume":"1","author":"Fossati","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0530","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2133.2007.07979.x","article-title":"Impaired cutaneous wound healing in granulocyte\/macrophage colony-stimulating factor knockout mice","volume":"157","author":"Fang","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0535","first-page":"75","article-title":"Local application of G-CSF, GM-CSF and EGF in treatment of wounds","volume":"53","author":"Grzybowski","year":"1999","journal-title":"Postepy higieny i medycyny doswiadczalnej"},{"key":"10.1016\/j.ejpb.2018.04.025_b0540","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.0022-202x.2001.01600.x","article-title":"Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization","volume":"117","author":"Mann","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0545","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2133.2009.09528.x","article-title":"Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines","volume":"162","author":"Fang","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0550","first-page":"107","article-title":"Recombinant human GM-CSF in the treatment of poorly healing wounds","volume":"13","author":"Groves","year":"2000","journal-title":"Adv. Skin Wound Care"},{"key":"10.1016\/j.ejpb.2018.04.025_b0555","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.burns.2010.08.016","article-title":"Topically applied rhGM-CSF for the wound healing: a systematic review","volume":"37","author":"Hu","year":"2011","journal-title":"Burns: J. Int. Soc. Burn Injuries"},{"key":"10.1016\/j.ejpb.2018.04.025_b0560","first-page":"187","article-title":"Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy","volume":"5","author":"Crawford","year":"1999","journal-title":"Cytokines Cell. Mol. Therapy"},{"key":"10.1016\/j.ejpb.2018.04.025_b0565","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF00311527","article-title":"Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis","volume":"25","author":"Katano","year":"1995","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejpb.2018.04.025_b0570","first-page":"175","article-title":"Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial","volume":"5","author":"Schneider","year":"1999","journal-title":"Cytokines Cell. Mol. Therapy"},{"key":"10.1016\/j.ejpb.2018.04.025_b0575","doi-asserted-by":"crossref","first-page":"e53252","DOI":"10.1371\/journal.pone.0053252","article-title":"Non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant","volume":"8","author":"Cesaro","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2018.04.025_b0580","first-page":"307","article-title":"Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation","volume":"11","author":"Linch","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0585","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.1995.13.10.2620","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy","volume":"13","author":"Chi","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0590","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(99)00452-6","article-title":"Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study","volume":"46","author":"Makkonen","year":"2000","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"key":"10.1016\/j.ejpb.2018.04.025_b0595","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1259\/bjr\/55190439","article-title":"Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer","volume":"79","author":"McAleese","year":"2006","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0600","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0605","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/cyto.1995.0064","article-title":"Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study","volume":"7","author":"Cartee","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2018.04.025_b0610","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0360-3016(02)02935-8","article-title":"Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study","volume":"54","author":"Saarilahti","year":"2002","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"key":"10.1016\/j.ejpb.2018.04.025_b0615","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdg177","volume":"14","author":"Dazzi","year":"2003","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0620","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s002770000264","article-title":"Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study","volume":"80","author":"van der Lelie","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0625","doi-asserted-by":"crossref","first-page":"409","DOI":"10.17219\/acem\/61913","article-title":"The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients","volume":"26","author":"Liang","year":"2017","journal-title":"Adv. Clin. Experimental Med.: Off. Organ Wroclaw Med. Univ."},{"key":"10.1016\/j.ejpb.2018.04.025_b0630","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-physiol-021115-105447","article-title":"Trefoil factor peptides and gastrointestinal function","volume":"79","author":"Aihara","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0635","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2362.2002.01014.x","article-title":"Effect of trefoil factors on the viscoelastic properties of mucus gels","volume":"32","author":"Thim","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2018.04.025_b0640","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0722.2007.00516.x","article-title":"Salivary trefoil factor 3 enhances migration of oral keratinocytes","volume":"116","author":"Storesund","year":"2008","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0645","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1007\/s00018-005-5481-9","article-title":"Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution","volume":"62","author":"Hoffmann","year":"2005","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.ejpb.2018.04.025_b0650","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1515\/CCLM.2011.667","article-title":"Trefoil factor family peptides are increased in the saliva of children with mucositis","volume":"49","author":"Verey","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0655","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jobcr.2015.06.009","article-title":"Trefoils: an unexplored natural protective shield of oral cavity","volume":"5","author":"Choudhary","year":"2015","journal-title":"J. Oral Biol. Craniofac. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0660","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.gastro.2003.12.004","article-title":"Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor","volume":"126","author":"Beck","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2018.04.025_b0665","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1002\/cncr.28365","article-title":"Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy","volume":"119","author":"Limaye","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0670","unstructured":"Determination of Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day."},{"key":"10.1016\/j.ejpb.2018.04.025_b0675","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157016109788340721","article-title":"Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury","volume":"7","author":"Cuneo","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0680","first-page":"33","article-title":"Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation","volume":"75","author":"Orazi","year":"1996","journal-title":"Lab. Invest. J. Tech. Methods Pathol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0685","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0972-124X.152108","article-title":"Interleukin-11 - its role in the vicious cycle of inflammation, periodontitis and diabetes: a clinicobiochemical cross-sectional study","volume":"19","author":"Prasad","year":"2015","journal-title":"J. Indian Soc. Periodontol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0690","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/13543784.7.9.1501","article-title":"The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease","volume":"7","author":"Trepicchio","year":"1998","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejpb.2018.04.025_b0695","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0964-1955(95)00015-A","article-title":"Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11","volume":"31B","author":"Sonis","year":"1995","journal-title":"Eur. J. Cancer Part B, Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0700","first-page":"734","article-title":"Repairing effects of interleukin 11 (IL-11) towards high dose methotrexate-induced rat small intestinal mucositis and its impacts on T-lymphoblastic leukemia cell line","volume":"19","author":"Han","year":"2016","journal-title":"Iranian J. Basic Med. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0705","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/cyto.1997.0208","article-title":"Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters","volume":"9","author":"Sonis","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2018.04.025_b0710","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1703394","article-title":"A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation","volume":"29","author":"Antin","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2018.04.025_b0715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"2015","key":"10.1016\/j.ejpb.2018.04.025_b0720","first-page":"D512","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0725","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13321-016-0160-4","article-title":"Jmol SMILES and Jmol SMARTS: specifications and applications","volume":"8","author":"Hanson","year":"2016","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ejpb.2018.04.025_b0730","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1357-2725(97)00128-3","article-title":"Transforming growth factor-beta (TGF-beta)","volume":"30","author":"Clark","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0735","first-page":"363","article-title":"Transforming growth factor-beta: a general review","volume":"7","author":"Lawrence","year":"1996","journal-title":"Eur. Cytokine Network"},{"key":"10.1016\/j.ejpb.2018.04.025_b0740","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.20910","article-title":"Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study","volume":"48","author":"de Koning","year":"2007","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0745","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1073\/pnas.82.1.119","article-title":"Type beta transforming growth factor: a bifunctional regulator of cellular growth","volume":"82","author":"Roberts","year":"1985","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2018.04.025_b0750","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6600342","article-title":"Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling","volume":"87","author":"van\u2019t Land","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0755","doi-asserted-by":"crossref","unstructured":"S. Antoun, V. Boige, M. Ducreux, M. Paintain, H. Martin van't, M. Enslen, P. Steenhout, E.J. Schiffrin, G. Nitenberg, Protective effect of an enteral formula containing TGF-\u03b22 in the prevention of chemotherapy-induced diarrhoea: A pilot study, Eur. e-J. Clin. Nutr. Metab, 4 e348-e350.","DOI":"10.1016\/j.eclnm.2009.10.005"},{"key":"10.1016\/j.ejpb.2018.04.025_b0760","unstructured":"M.C. Foncuberta, P.J. Cagnoni, C.H. Brandts, R. Mandanas, K. Fields, H.G. Derigs, E. Reed, S.T. Sonis, J. Fay, F. LeVeque, P. Pouillart, H. Schrezenmeier, R. Emmons, E. Thiel, T.G.F.b.O.M.S.P. Investigators in, Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors, J. Immunother. (Hagerstown, Md.: 1997), 24 (2001) 384\u2013388."},{"key":"10.1016\/j.ejpb.2018.04.025_b0765","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b0770","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejpb.2010.11.023","article-title":"Manufacture and characterization of mucoadhesive buccal films","volume":"77","author":"Morales","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0775","series-title":"Pediatric Formulations","first-page":"3","article-title":"Paediatric development: anatomy. Age, weight, body surface and stature, organ development","author":"Batchelor","year":"2014"},{"key":"10.1016\/j.ejpb.2018.04.025_b0780","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/00220345870660080201","article-title":"The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa","volume":"66","author":"Collins","year":"1987","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0785","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.2174\/138161212803307545","article-title":"Mucoadhesive polymers for oral transmucosal drug delivery: a review","volume":"18","author":"Bagan","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2018.04.025_b0790","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.10.021","article-title":"The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model","volume":"84","author":"Teubl","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0795","first-page":"15","article-title":"Buccal mucosa as a route for systemic drug delivery: a review","volume":"1","author":"Shojaei","year":"1998","journal-title":"J. Pharm. Pharm. Sci.: Publ. Can. Soc. Pharm. Sci., Societe canadienne des sciences pharmaceutiques"},{"key":"10.1016\/j.ejpb.2018.04.025_b0800","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1208\/s12249-016-0567-2","article-title":"Buccal dosage forms: general considerations for pediatric patients","volume":"18","author":"Montero-Padilla","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.04.025_b0805","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0810","first-page":"58","article-title":"Role of topical drugs in treatment of oral mucosal diseases. A literature review","volume":"79","author":"Sheikh","year":"2013","journal-title":"New York State Dental J."},{"key":"10.1016\/j.ejpb.2018.04.025_b0815","first-page":"271","article-title":"Developments in buccal drug delivery","volume":"8","author":"de Vries","year":"1991","journal-title":"Crit. Rev. Therapeutic Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2018.04.025_b0820","series-title":"Oral Mucosal Drug Delivery and Therapy","author":"Rathbone","year":"2015"},{"key":"10.1016\/j.ejpb.2018.04.025_b0825","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1081\/DDC-120024178","article-title":"Buccal delivery systems","volume":"29","author":"Hao","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-409X(93)90037-5","article-title":"Regional variation in the structure and permeability of oral-mucosa and skin","volume":"12","author":"Wertz","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b0835","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0169-409X(93)90038-6","article-title":"Permeability and the pathophysiology of oral-mucosa","volume":"12","author":"Squier","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b0840","first-page":"467","article-title":"Regional variation in oral mucosal drug permeability","volume":"17","author":"Kurosaki","year":"2000","journal-title":"Crit. Rev. Therapeutic Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2018.04.025_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.01.024","article-title":"Buccal penetration enhancers\u2013how do they really work?","volume":"105","author":"Nicolazzo","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b0850","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1128\/JVI.00443-13","article-title":"Epstein-barr virus transcytosis through polarized oral epithelial cells","volume":"87","author":"Tugizov","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0855","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2017.00089","article-title":"Radiation-induced oral mucositis","volume":"7","author":"Maria","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0860","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0973-1075.58452","article-title":"Radiation induced oral mucositis","volume":"15","author":"Ps","year":"2009","journal-title":"Indian J. Palliat. Care"},{"key":"10.1016\/j.ejpb.2018.04.025_b0865","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0870","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00520-015-2964-6","article-title":"Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer","volume":"24","author":"Wardill","year":"2016","journal-title":"Supportive Care Cancer: Off. J. Multinational Assoc. Supportive Care Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b0875","first-page":"340","article-title":"Prevention and treatment of oral mucositis in children with cancer","volume":"17","author":"Miller","year":"2012","journal-title":"J. Pediatric Pharmacol. Therap.: JPPT: Off. J. PPAG"},{"key":"10.1016\/j.ejpb.2018.04.025_b0880","doi-asserted-by":"crossref","unstructured":"P. Riley, A.M. Glenny, H.V. Worthington, A. Littlewood, J.E. Clarkson, M.G. McCabe, Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy, Cochrane Database Syst. Rev. (2015) CD011552.","DOI":"10.1002\/14651858.CD011552"},{"key":"10.1016\/j.ejpb.2018.04.025_b0885","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/jid.1966.115","article-title":"The effects of aging upon oral mucosa**From the Department of Oral Pathology, Tufts University School of Dental Medicine, Boston, Massachusetts. This project was supported by Grant DE-01861-02. National Institutes of Health (N.I.D.R.)","volume":"47","author":"Shklar","year":"1966","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0890","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11357-011-9261-1","article-title":"Age and the architecture of oral mucosa","volume":"34","author":"Abu Eid","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.ejpb.2018.04.025_b0895","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0003-9969(88)90182-3","article-title":"Influence of age on the morphology and transit time of murine stratified squamous epithelia","volume":"33","author":"Hill","year":"1988","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0900","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i4.20","article-title":"Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity","volume":"21","author":"Smart","year":"2004","journal-title":"Crit. Rev. Therap. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2018.04.025_b0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.2600810102","article-title":"Drug delivery via the mucous membranes of the oral cavity","volume":"81","author":"Harris","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0910","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/03639045.2014.892959","article-title":"Mucoadhesive polymers for buccal drug delivery","volume":"40","author":"Laffleur","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0915","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1567201811666140924124722","article-title":"Mucoadhesive polymeric platform for drug delivery; a comprehensive review","volume":"12","author":"Agarwal","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.04.025_b0920","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/03639040802026012","article-title":"Polymers for mucoadhesive drug delivery system: a current status","volume":"34","author":"Asane","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0925","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i3.20","article-title":"Advances in buccal drug delivery","volume":"22","author":"Birudaraj","year":"2005","journal-title":"Crit. Rev. Therap. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2018.04.025_b0930","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0003-9969(03)00086-4","article-title":"Minor salivary gland secretion in children and adults","volume":"48","author":"Sonesson","year":"2003","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b0935","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0928-0987(99)00070-6","article-title":"Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method","volume":"9","author":"Hagerstrom","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0940","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s002590050227","article-title":"Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?","volume":"25","author":"Rodrigues","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b0945","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0749-2081(05)80005-1","article-title":"The symptom experience of mucositis, stomatitis, and xerostomia","volume":"11","author":"Dose","year":"1995","journal-title":"Semin. Oncol. Nursing"},{"key":"10.1016\/j.ejpb.2018.04.025_b0950","unstructured":"A. Shih, C. Miaskowski, M.J. Dodd, N.A. Stotts, L. MacPhail, Mechanisms for radiation-induced oral mucositis and the consequences, 26 (2003) 222\u2013229."},{"key":"10.1016\/j.ejpb.2018.04.025_b0955","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jds.2015.01.004","article-title":"Effects of radiotherapy on salivary gland function in patients with head and neck cancers","volume":"10","author":"Lin","year":"2015","journal-title":"J. Dental Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0960","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","article-title":"Management of oral mucositis in patients who have cancer","volume":"52","author":"Lalla","year":"2008","journal-title":"Dent. Clin. North Am."},{"key":"10.1016\/j.ejpb.2018.04.025_b0965","first-page":"242","article-title":"Formulation design and evaluation of bilayer buccal tablets of granisetron hydrochloride","volume":"1","author":"Pv","year":"2010","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b0970","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/03639045.2011.644294","article-title":"Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs","volume":"38","author":"Kianfar","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b0975","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2018.04.025_b0980","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.bpj.2012.01.060","article-title":"Toward a molecular understanding of protein solubility: increased negative surface charge correlates with increased solubility","volume":"102","author":"Kramer","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2018.04.025_b0985","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0142-9612(85)90101-2","article-title":"Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities","volume":"6","author":"van Wachem","year":"1985","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.04.025_b0990","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/000163598428400","article-title":"Antimicrobial function of human saliva\u2013how important is it for oral health?","volume":"56","author":"Tenovuo","year":"1998","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.ejpb.2018.04.025_b0995","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0976-9668.82322","article-title":"Science behind human saliva","volume":"2","author":"Tiwari","year":"2011","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b1000","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.archoralbio.2007.09.007","article-title":"Effect of childhood malnutrition on salivary flow and pH","volume":"53","author":"Psoter","year":"2008","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/00016357.2011.654238","article-title":"Effect of a third application of toothpastes (1450 and 5000 ppm F), including a 'massage' method on fluoride retention and pH drop in plaque","volume":"71","author":"Nordstrom","year":"2013","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.ejpb.2018.04.025_b1010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2015.01.007","article-title":"Characterisation of human saliva as a platform for oral dissolution medium development","volume":"91","author":"Gittings","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2013.04.054","article-title":"Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients","volume":"452","author":"Santana","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1110\/ps.0230103","article-title":"pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor","volume":"12","author":"Ricci","year":"2003","journal-title":"Protein Sci.: Publ. Protein Soc."},{"key":"10.1016\/j.ejpb.2018.04.025_b1025","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jps.10440","article-title":"Structural characterization of bovine granulocyte colony stimulating factor: effect of temperature and pH","volume":"92","author":"Kueltzo","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.peptides.2007.03.016","article-title":"Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents","volume":"28","author":"Kjellev","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2018.04.025_b1035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/092986608783744243","article-title":"Stability and biological activity of human intestinal trefoil factor produced by pichia pastoris","volume":"15","author":"Xi","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejpb.2018.04.025_b1040","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1074\/jbc.274.12.7699","article-title":"Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions","volume":"274","author":"Pellaud","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2018.04.025_b1045","series-title":"Formulation, Characterization, and Stability of Protein Drugs","author":"Pearlman","year":"1996"},{"key":"10.1016\/j.ejpb.2018.04.025_b1050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1023\/A:1018945727640","article-title":"Acid-catalyzed peptide bond hydrolysis of recombinant human interleukin 11","volume":"11","author":"Kenley","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2005.05.029","article-title":"The effects of bivalent inorganic salts on the mucoadhesive performance of a polymethylmethacrylate sodium salt","volume":"301","author":"Cilurzo","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.snb.2007.01.022","article-title":"Rheological, dielectric and diffusion analysis of mucin\/carbopol matrices used in amperometric biosensors","volume":"124","author":"Capra","year":"2007","journal-title":"Sens. Actuators B-Chem."},{"key":"10.1016\/j.ejpb.2018.04.025_b1065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","article-title":"Drug transfer through mucus","volume":"48","author":"Khanvilkar","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b1070","first-page":"12","article-title":"Oral mucositis in children suffering from acute lymphoblastic leukaemia","volume":"16","author":"Pels","year":"2012","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"10.1016\/j.ejpb.2018.04.025_b1075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.07.016","article-title":"Orotransmucosal drug delivery systems: a review","volume":"140","author":"Madhav","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b1080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/IAI.53.2.359-365.1986","article-title":"Preparation of a sialic acid-binding protein from Streptococcus mitis KS32AR","volume":"53","author":"Murray","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejpb.2018.04.025_b1085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/00365520701579662","article-title":"Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis","volume":"43","author":"Saegusa","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1749-6632.1963.tb16670.x","article-title":"The effect of radiation on the production of mucin in salivary glands and the female genital tract of rodents","volume":"106","author":"Glucksmann","year":"1963","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1095","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: function, prognosis and therapy","volume":"9","author":"Kufe","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2018.04.025_b1100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0168-3659(85)90050-1","article-title":"Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues","volume":"2","author":"Peppas","year":"1985","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b1105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0003-9861(87)90366-3","article-title":"Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva","volume":"258","author":"Loomis","year":"1987","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2018.04.025_b1110","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1208\/s12249-010-9479-8","article-title":"The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate","volume":"11","author":"Sakloetsakun","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.04.025_b1115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(91)90287-X","article-title":"An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop","volume":"70","author":"Lehr","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","article-title":"Mucoadhesive polymeric platforms for controlled drug delivery","volume":"71","author":"Andrews","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1125","first-page":"367","article-title":"Noninvasive routes of proteins and peptides drug delivery","volume":"73","author":"Jitendra","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(86)90137-7","article-title":"Aminopeptidase activity in homogenates of various absorptive mucosae m the albino rabbit: implications in peptide delivery","volume":"30","author":"Stratford","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-5173(00)00394-X","article-title":"Romer Rassing, TR146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leu-enkephalin","volume":"200","author":"Morck","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0939-6411(00)00144-2","article-title":"Factors and strategies for improving buccal absorption of peptides","volume":"51","author":"Veuillez","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1145","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/0024-3205(90)90492-A","article-title":"Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes","volume":"47","author":"Yamamoto","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1150","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/0024-3205(86)90150-5","article-title":"Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases","volume":"38","author":"Kashi","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1155","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1023\/A:1015883217858","article-title":"Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro","volume":"9","author":"Dowty","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1601-0825.2007.01415.x","article-title":"Expression of two drug-metabolizing cytochrome P450-enzymes in human salivary glands","volume":"14","author":"Kragelund","year":"2008","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejpb.2018.04.025_b1165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(01)00934-6","article-title":"Peptidase activity on the surface of the porcine buccal mucosa","volume":"233","author":"Walker","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1170","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0022034515581012","article-title":"Epithelial cell apoptosis in recurrent aphthous ulcers","volume":"94","author":"Al-Samadi","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1175","first-page":"385","article-title":"Y. Madhusudan Rao, A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods","volume":"19","author":"Chinna Reddy","year":"2011","journal-title":"Daru"},{"key":"10.1016\/j.ejpb.2018.04.025_b1180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0928-0987(95)00042-9","article-title":"Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes","volume":"4","author":"Lue\u00dfen","year":"1996","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1185","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1023\/A:1012108118670","article-title":"Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N","volume":"14","author":"Bernkop-Schnurch","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2004.03.032","article-title":"Thiomers: potential excipients for non-invasive peptide delivery systems","volume":"58","author":"Bernkop-Schnurch","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/152091502760306544","article-title":"Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2","volume":"4","author":"Clement","year":"2002","journal-title":"Diabetes Technol. Therap."},{"key":"10.1016\/j.ejpb.2018.04.025_b1200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2217\/17435889.3.6.845","article-title":"Nanoparticles as protein and gene carriers to mucosal surfaces","volume":"3","author":"de la Fuente","year":"2008","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ejpb.2018.04.025_b1205","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.addr.2005.07.003","article-title":"The use of mucoadhesive polymers in buccal drug delivery","volume":"57","author":"Salamat-Miller","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.025_b1210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0003-9969(84)90036-0","article-title":"Permeability of the rat oral mucosa to organic solutes measured in vivo","volume":"29","author":"Siegel","year":"1984","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0003-9969(81)90030-3","article-title":"Mechanisms of non-electrolyte penetration across dog and rabbit oral mucosa in vitro","volume":"26","author":"Siegel","year":"1981","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-3659(92)90017-L","article-title":"Buccal delivery for peptide drugs","volume":"21","author":"Merkle","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b1225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/03639040903117348","article-title":"Critical evaluation of permeation enhancers for oral mucosal drug delivery","volume":"36","author":"Sohi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1230","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0142-9612(00)00134-4","article-title":"Enhancing effect of chitosan on peptide drug delivery across buccal mucosa","volume":"21","author":"Senel","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.04.025_b1235","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1110\/ps.440101","article-title":"The effect of net charge on the solubility, activity, and stability of ribonuclease Sa","volume":"10","author":"Shaw","year":"2001","journal-title":"Protein Sci.: Publ. Protein Soc."},{"key":"10.1016\/j.ejpb.2018.04.025_b1240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0378-5173(92)90308-O","article-title":"The effect of drug charge type and charge-density on corneal transport","volume":"88","author":"Liaw","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1245","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1015802427428","article-title":"The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit","volume":"9","author":"Rojanasakul","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/gut.37.3.335","article-title":"Epidermal growth factor in saliva and gastric juice: response to histamine","volume":"37","author":"Tunio","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2018.04.025_b1255","first-page":"17","article-title":"Role of saliva, salivary glands and epidermal growth factor (EGF) on oral wound healing","volume":"96","author":"Nagy","year":"2003","journal-title":"Fogorv. Sz."},{"key":"10.1016\/j.ejpb.2018.04.025_b1260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1515\/CCLM.2011.123","article-title":"Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals","volume":"49","author":"Samson","year":"2011","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b1265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/mp.56.1.52","article-title":"Salivary gland expression of transforming growth factor \u03b2 isoforms in Sjogren\u2019s syndrome and benign lymphoepithelial lesions","volume":"56","author":"Mason","year":"2003","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1270","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2353\/ajpath.2009.080723","article-title":"Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues","volume":"174","author":"Vitsky","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1275","unstructured":"K.I. Matsuda, M. Takebe, T. Inou, Y. Gotoh, M. Tamashige, Y. Komori, H. Chiba, Study on G-CSF in saliva regarding the defense mechanism of oral infections \u2013 Part 1 concentration of G-CSF in saliva, 1996."},{"key":"10.1016\/j.ejpb.2018.04.025_b1280","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1110\/ps.9.7.1395","article-title":"Charge-charge interactions influence the denatured state ensemble and contribute to protein stability","volume":"9","author":"Pace","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1285","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1074\/jbc.M112.426254","article-title":"Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome","volume":"288","author":"Rajam\u00e4ki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2018.04.025_b1290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(02)00018-7","article-title":"pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque","volume":"164","author":"Naghavi","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejpb.2018.04.025_b1295","first-page":"468","article-title":"Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints","volume":"16","author":"Geborek","year":"1989","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1300","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1164\/ajrccm.161.3.9911005","article-title":"Endogenous airway acidification. Implications for asthma pathophysiology","volume":"161","author":"Hunt","year":"2000","journal-title":"Am. J. Respiratory Crit. Care Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b1305","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02656739509022457","article-title":"Extracellular pH distribution in human tumours","volume":"11","author":"Engin","year":"1995","journal-title":"Int. J. Hyperthermia: Off. J. Eur. Soc. Hyperthermic Oncol. North American Hyperthermia Group"},{"key":"10.1016\/j.ejpb.2018.04.025_b1310","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0002-9343(78)90446-1","article-title":"Acidosis of synovial fluid correlates with synovial fluid leukocytosis","volume":"64","author":"Ward","year":"1978","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejpb.2018.04.025_b1315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40119-013-0022-3","article-title":"Lp-PLA(2) inhibitors for the reduction of cardiovascular events","volume":"2","author":"Steen","year":"2013","journal-title":"Cardiol. Therapy"},{"key":"10.1016\/j.ejpb.2018.04.025_b1320","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.redox.2017.12.018","article-title":"Extracellular acidification induces ROS- and mPTP-mediated death in HEK293 cells","volume":"15","author":"Teixeira","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1325","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.ejpb.2018.04.025_b1330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2010.02.025","article-title":"Protein aggregation\u2013pathways and influencing factors","volume":"390","author":"Wang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1335","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.05.258","article-title":"Oral films as breakthrough tools for oral delivery of proteins\/peptides","volume":"211","author":"Castro","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b1340","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejpb.2018.04.025_b1345","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2174\/092986712799945003","article-title":"Converting peptides into drug leads by lipidation","volume":"19","author":"Zhang","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2018.04.025_b1350","unstructured":"K. Phelps, The Emergence Of Prodrugs: A Proficient Pathway To New Drug Development Through The 505(b)(2) Pathway, in: O. Pharma (Ed.), 2014."},{"key":"10.1016\/j.ejpb.2018.04.025_b1355","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","article-title":"Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications","volume":"41","author":"Zhang","year":"2002","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1360","series-title":"Medical Applications of Liposomes","first-page":"9","article-title":"Liposome research in drug delivery and targeting: thoughts of an early participant","author":"Gregoriadis","year":"1998"},{"key":"10.1016\/j.ejpb.2018.04.025_b1365","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2005.11.006","article-title":"Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation","volume":"308","author":"El-Samaligy","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1370","article-title":"Formulation and evaluation of rifampicin liposomes for buccal","author":"Srinivas","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.04.025_b1375","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2015.04.052","article-title":"Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins","volume":"488","author":"Abd El Azim","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1380","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1248\/cpb.50.749","article-title":"Phospholipid deformable vesicles for buccal delivery of insulin","volume":"50","author":"Yang","year":"2002","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejpb.2018.04.025_b1385","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1390","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s11095-009-9882-6","article-title":"Diffusion studies of nanometer polymersomes across tissue engineered human oral mucosa","volume":"26","author":"Hearnden","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1395","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijpharm.2017.04.025","article-title":"Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen","volume":"533","author":"Marques","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-800148-6.00011-0","article-title":"Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics","volume":"88","author":"Martirosyan","year":"2014","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ejpb.2018.04.025_b1405","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jfda.2015.01.007","article-title":"Application of polymeric nanoparticles and micelles in insulin oral delivery","volume":"23","author":"Alai","year":"2015","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ejpb.2018.04.025_b1410","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: Revisited approaches","volume":"33","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejpb.2018.04.025_b1415","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coph.2017.07.011","article-title":"Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles","volume":"36","author":"Morales","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.04.025_b1425","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.03.061","article-title":"Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins","volume":"392","author":"Mohanraj","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1430","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s11095-010-0121-y","article-title":"Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies","volume":"27","author":"Holpuch","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.025_b1435","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/03639040802596212","article-title":"Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol","volume":"35","author":"Jug","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.025_b1440","unstructured":"S. Jagdale, P. Mohanty, A. Chabukswar, B. S. Kuchekar, Development of Buccal Patches for Delivery of Darifenacin from Beta-Cyclodextrin Complexes, 2014."},{"key":"10.1016\/j.ejpb.2018.04.025_b1445","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/js990163p","article-title":"Increased bioavailability of clomipramine after sublingual administration in rats","volume":"88","author":"Yoo","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1450","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jps.2600761007","article-title":"gamma-Cyclodextrin:testosterone complex suitable for sublingual administration","volume":"76","author":"Pitha","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.025_b1455","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1208\/s12249-010-9546-1","article-title":"A comprehensive development strategy in buccal drug delivery","volume":"11","author":"Figueiras","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.04.025_b1460","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1016\/j.actbio.2013.07.030","article-title":"Dual growth factor releasing multi-functional nanofibers for wound healing","volume":"9","author":"Xie","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.04.025_b1465","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.carbpol.2015.12.014","article-title":"Layer-by-layer polysaccharide-coated liposomes for sustained delivery of epidermal growth factor","volume":"140","author":"Kaminski","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2018.04.025_b1470","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/02652048.2011.646327","article-title":"Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system","volume":"29","author":"Jeon","year":"2012","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2018.04.025_b1475","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1524-475X.2010.00612.x","article-title":"Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats","volume":"18","author":"Chu","year":"2010","journal-title":"Wound Repair Regeneration: Off. Publ. Wound Healing Soc. [and] Eur. Tissue Repair Soc."},{"key":"10.1016\/j.ejpb.2018.04.025_b1480","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.biomaterials.2005.11.043","article-title":"A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors","volume":"27","author":"Chung","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.04.025_b1485","first-page":"5247","article-title":"Enhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomes","volume":"9","author":"Qin","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2018.04.025_b1490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15171\/bi.2016.26","article-title":"Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size","volume":"6","author":"Kiafar","year":"2016","journal-title":"BioImpacts: BI"},{"key":"10.1016\/j.ejpb.2018.04.025_b1495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(97)00194-6","article-title":"Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF)","volume":"52","author":"Gibaud","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.025_b1500","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1021\/acs.bioconjchem.7b00605","article-title":"Granulocyte colony-stimulating factor nanocarriers for stimulation of the immune system (Part I): synthesis and biodistribution studies","volume":"29","author":"De Crozals","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejpb.2018.04.025_b1505","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/21655979.2016.1212136","article-title":"Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy","volume":"8","author":"Vanitha","year":"2017","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejpb.2018.04.025_b1510","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/1043-4666(94)90014-0","article-title":"Cytokines in liposomes: Preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-\u03b3","volume":"6","author":"Anderson","year":"1994","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2018.04.025_b1515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jbm.a.30187","article-title":"Efficiency of magnetic liposomal transforming growth factor-beta 1 in the repair of articular cartilage defects in a rabbit model","volume":"73","author":"Tanaka","year":"2005","journal-title":"J Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2018.04.025_b1520","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3727\/095535489820875084","article-title":"Antiproliferative activity of liposome-encapsulated transforming growth factor-beta against MDA-MB-435 human breast carcinoma cells","volume":"1","author":"Fan","year":"1989","journal-title":"Cancer Commun."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T07:33:03Z","timestamp":1604215983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111830050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":304,"alternative-id":["S093964111830050X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.025","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the local delivery of peptides and proteins for oral mucositis management","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}